Fundraising Fox

Histogen

San Diego, US · Delaware corporation · 1 known investors

Biotech

Founders & leadership

GN
Gail NaughtonFounder
SA
Susan A. KnudsonExecutive
RW
Richard W. PascoeExecutive
DK
Daniel Kisner, M.D.Named on SEC filing
SM
Steven Mento, Ph.D.Named on SEC filing
BS
Brian Satz, Esq.Named on SEC filing
HY
Hayden Yizhuo ZhangNamed on SEC filing
ML
Martin LatterichNamed on SEC filing
SC
Stephen Chang, Ph.D.Named on SEC filing
JJ
Jonathan JacksonNamed on SEC filing
MD
Moya DanielsNamed on SEC filing

Board

DC
David Crean, Ph.D.Board director

Investors · 1

1004 Venture PartnersreportedSan Diegovia David H. Crean · board

Reported raises · per SEC filings

Form D private placements

$45.6M disclosed across 6 of 7 rounds · 2007–2022

▶$5MraisedJul 2022 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David H. CreanDirector
  • Martin LatterichExecutive Officer
  • Jonathan JacksonDirector
  • Susan Windham-BannisterDirector
  • Daniel L. KisnerDirector
  • Susan A. KnudsonExecutive Officer
  • Rochelle FuhrmannDirector
  • Gail K. NaughtonExecutive Officer
  • Joyce ReyesExecutive Officer
  • Steven J. MentoExecutive Officer, Director
  • Brian SatzDirector
Offering amount
$5M
Amount sold
$5M
Sales commissions
$486.1K
Placement agents
H.C. Wainwright & Co., LLC
First sale
Jul 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$189.2KraisedNov 2020 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel Kisner, M.D.Director
  • Steven Mento, Ph.D.Director
  • Brian Satz, Esq.Director
  • Hayden Yizhuo ZhangDirector
  • Susan A. KnudsonExecutive Officer
  • Gail NaughtonExecutive Officer
  • Martin LatterichExecutive Officer
  • Stephen Chang, Ph.D.Director
  • David Crean, Ph.D.Director
  • Richard W. PascoeExecutive Officer, Director
  • Jonathan JacksonDirector
  • Moya DanielsExecutive Officer
Offering amount
$189.2K
Amount sold
$189.2K
Sales commissions
$154.3K
Placement agents
H.C. Wainwright & Co., LLC
First sale
Nov 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15.3MraisedSep 2019 · 47 investors · Biotechnology
Rule 506(c)
Officers, directors & promoters on the filing
  • Richard PascoeExecutive Officer, Director
  • Brian SatzDirector
  • Jonathan JacksonDirector
  • Yizhuo ZhangDirector
  • Stephen ChangDirector
  • David CreanDirector
Offering amount
$30M
Amount sold
$15.3M
First sale
Aug 2016
Incorporated
Corporation, Delaware
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$10.4MraisedJun 2015 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Gail NaughtonExecutive Officer
Offering amount
$10.4M
Amount sold
$10.4M
First sale
Apr 2013
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$9.5MraisedJun 2015 · 65 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Gail NaughtonExecutive Officer
Offering amount
$9.5M
Amount sold
$9.5M
First sale
Dec 2007
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$18MofferedJun 2015 · Biotechnology
Rule 506(c)
Officers, directors & promoters on the filing
  • Gail NaughtonExecutive Officer
Offering amount
$18M
Minimum investment
$100K
Sales commissions
$900K
Placement agents
Gar Wood Securities, WealthForge, LLC
Incorporated
Corporation, Delaware
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$5.2MraisedJun 2015 · 34 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Gail NaughtonExecutive Officer
Offering amount
$5.2M
Amount sold
$5.2M
Minimum investment
$100K
First sale
Dec 2010
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who founded Histogen?
Histogen was founded by Gail Naughton.
Who are Histogen's investors?
Histogen's investors include 1004 Venture Partners.
How much funding has Histogen raised?
Histogen has disclosed $45.6M raised across 6 of its 7 known rounds.
Where is Histogen headquartered?
Histogen is headquartered in San Diego, US.